Boston Scientific may sell endosurgery unit stake
556891
Boston Scientific Corp. , saddled with debt and a depressed share price since buying Guidant Corp., said on Monday it may sell a minority stake in its endosurgery business for more than $1 billion in a public offering.
644093
Boston Scientific Corp. said yesterday it sold $8.3 million worth of its Taxus drug-coated cardiac stents per day this month, a record level the Natick medical
154164
LaBranche & Co. Inc. , which runs one of the largest equity specialist traders on the New York Stock Exchange floor, may consider selling all or part of itself to salvage its floor-trading business, a person familiar with the matter said on Monday.
459813
Time is running out for Boston Scientific to resolve what could be a multibillion-dollar liability resulting from its foray into the stent business.
458093
The continued dominance of Boston's healthcare industry, the region's largest employer, could be undermined by stagnant federal funding for biomedical research, combined with the city's chronically high cost of living and competition from other cities, according to a report by an industry group.
700160
Boston Scientific Corp. shipped millions of dollars worth of coronary stents in fall 1998 even after company officials learned that the medical devices had
52182
A majority ownership stake in 454 Life Sciences could pay hefty dividends.
405260
Johnson &amp; Johnson is picking a price fight over drug-coated stents. Does Boston Scientific Corp. need to respond?
665486
Its sale of a chemotherapy drug indicates it could recoup what it paid for its ESP assets.
170214
BERLIN - Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private US investment groups Cerberus Capital Management and Ampersand Ventures.
97721
Boston Scientific Corp. and Medtronic Inc. , competing to enter the US market for stents that keep neck arteries open, said separate studies showed their devices prevent complications including stroke after 30 days.
658871
Boston Scientific Corp. , the medical device maker, eliminated 55 jobs in Marlborough last month, according to the state Executive Office of Labor and Workforce Development. Company spokesman Paul Donovan said the Natick firm made the cuts after deciding to pull the plug on its Endovations program, an effort to develop a new single-use endoscope with an integrated ...
392067
Boston Life Sciences Inc. said it is seeking the approval of shareholders for a reverse stock split of its issued and outstanding common shares. According to a proxy statement filed with the Securities and Exchange Commission, the company seeks approval for any of a 1-for-5, 1-for-10, or 1-for-15 reverse stock spilt at its annual meeting Jan. 28. Boston Life Sciences ...
566265
A group of Boston businessmen including former General Electric chief executive Jack Welch, advertising executive Jack Connors, and concessionaire Joe O'Donnell may make a bid for The Boston Globe next year, according to a report in the Wall Street Journal.
646222
The anticipated merger of Guidant Corp. and Johnson &amp; Johnson could give an unintended boost to Boston Scientific Corp. if Guidant's drug-coated stent launch is delayed, said analysts looking at the implications of a potential deal.
155100
Standard &amp; Poor's raised its outlook on Boston Scientific Corp. to positive from stable, citing its recovery of market share for its drug-coated Taxus cardiac stent after recalls that began in July. The debt rating agency said the upgrade reflects the Natick company's &quot;surprisingly rapid recovery&quot; of market share for Taxus, and its diverse product line. Last week, Boston Scientific ...
561735
Advanced Medical Optics Inc.  said on Thursday it was interested in acquiring Bausch & Lomb Inc.  and was willing to pay more than the $3.67 billion proposal the eye-care company accepted from a private equity firm.